roger_marc_12

Novasep announces changes at the top

pharmafile | October 9, 2012 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development Novasep, Patrick Glaser, Roger-Marc Nicoud, manufacturing 

Novasep has announced the appointment of Roger-Marc Nicoud, founder and chief executive, as non-executive chairman of the Board.

The manufacturing firm for the life sciences industry has added that Patrick Glaser, who has been in charge of the Novasep Synthesis division since May 2010, has become president and chief executive.

Nicoud (pictured) said: “As the founder of Novasep and having managed the firm for over 20 years, I think it is the right time for a change in the company’s leadership. In a short period of time, our new shareholders have demonstrated their commitment to support the growth of our business by endorsing significant investment, so that we are in a position to take full advantage of our unique leadership in purification technologies.

Advertisement

“I have been working with Patrick for more than two years and during that time he has successfully grown our chemical activities. I am happy to see him as my successor. With recent sizeable commercial successes, committed shareholders and talented management, Novasep is in good hands.”

Thomas Devedjian, director – executive Board member of Fonds Stratégique d’Investissement (FSI), declared: “We would like to thank Roger-Marc Nicoud for his very strong involvement in the recovery of the Company through the recent refinancing and different promising projects such as the new anti-cancer molecules production capacities in Le Mans. We thus are very confident in the future development of Novasep.”

Related Content

CARBOGEN AMCIS manufacturing license advances services in China

Swiss pharma manufacturing company, CARBOGEN AMCIS, has announced that its facility in Shanghai, China, has …

Meribel Pharma Solutions launches to take pharma services to new heights

Meribel Pharma Solutions, a new mid-sized contract development and manufacturing organisation (CDMO), has officially launched …

Bend Bioscience adds commercial spray drying facility to Georgia site

Bend Bioscience has announced the addition of a commercial-scale spray dryer and a Gerteis dry …

The Gateway to Local Adoption Series

Latest content